INTERNAL-USE SOFTWARE, NET
|6 Months Ended|
Jun. 30, 2021
|Research and Development [Abstract]|
|INTERNAL-USE SOFTWARE, NET||INTERNAL-USE SOFTWARE, NET
Internal-use software, net consists of the following:
The aggregate amortization expense for internal-use software, net is reflected in "Depreciation and amortization" in the Consolidated Statements of Operations. During the three months ended June 30, 2021 and 2020, the Company capitalized internal-use software development costs of $8.1 million and $6.1 million, respectively, and during the during the six months ended June 30, 2021 and 2020, the Company capitalized internal-use software development costs of $15.0 million and $12.0 million, respectively. Total amortization expense associated with its capitalized internal-use software development costs for the three months ended June 30, 2021 and 2020 was $6.1 million and $4.6 million, respectively, and for the six months ended June 30, 2021 and 2020 was $11.3 million and $8.9 million, respectively. There were no write-offs or impairment charges recorded for the three and six months ended June 30, 2021 and 2020.
The entire disclosure for research, development, and computer software activities, including contracts and arrangements to be performed for others and with federal government. Includes costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility and in-process research and development acquired in a business combination consummated during the period.
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef